12.05.13
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, has entered into a three-year distribution agreement with Brenntag Specialities, Inc. The non-exclusive agreement provides Brenntag the worldwide rights to distribute PURE's proprietary SDC-based antimicrobial SILVÉRION 2400 as an active ingredient or preservative for use in personal care products.
The Company stated that the distribution agreement with Brenntag is consistent with its new business strategy to out-license its antimicrobial SDC-technology in non-core operating activities for commercialization with industry and market leading companies.
The Company stated that the distribution agreement with Brenntag is consistent with its new business strategy to out-license its antimicrobial SDC-technology in non-core operating activities for commercialization with industry and market leading companies.